APO RESEARCH · REPORT
Chondroitin
Chondroitin is a chondrin derivative, generally is Chondroitin sulfate.
Product & engineering
Understand the product.
Chondroitin is a chondrin derivative, generally is Chondroitin sulfate.
Chondroitin sulfate is a sulfated glycosaminoglycan (GAG) composed of a chain of alternating sugars (N-acetylgalactosamine and glucuronic acid). It is usually found attached to proteins as part of a proteoglycan. A chondroitin chain can have over 100 individual sugars, each of which can be sulfated in variable positions and quantities. Chondroitin sulfate is an important structural component of cartilage and provides much of its resistance to compression. Along with glucosamine, chondroitin sulfate has become a widely used dietary supplement for treatment of osteoarthritis.
Selected research
Industry Research
Chondroitin Industry Research Report 2026
Market perspective
Chondroitin is a chondrin derivative, generally is Chondroitin sulfate.
Chondroitin sulfate is a sulfated glycosaminoglycan (GAG) composed of a chain of alternating sugars (N-acetylgalactosamine and glucuronic acid). It is usually found attached to proteins as part of a proteoglycan. A chondroitin chain can have over 100 individual sugars, each of which can be sulfated in variable positions and quantities. Chondroitin sulfate is an important structural component of cartilage and provides much of its resistance to compression. Along with glucosamine, chondroitin sulfate has become a widely used dietary supplement for treatment of osteoarthritis.
Global Chondroitin Sulfate key players include SANXIN, WanTuMing Biological, TSI Group, Yantai Dongcheng, Focus Chem, etc. Global top five manufacturers hold a share over 25%.
Read the full market overview
China is the largest market, with a share over 75%, followed by Europe and North America, both have a share over 10%.
In terms of product, Food Grade is the largest segment, with a share over 70%.
Report Scope
This report quantifies the global Chondroitin market in terms of revenue (US$ million) and, where applicable, sales volume (Ton), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Ton) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Chondroitin Market by Company
SANXIN
Focus Chem
GGI
Guanglong Biochem
Hengjie Bio-Pharmaceuticals
Huiwen
ISBA
Jiaixng Hengjie
Meitek
Nippon Zoki
Pacific Rainbow
Qingdao Green-Extract
QJBCHINA
Runxin Biotechnology
SANXIN GROUP
Shandong Dongcheng
Sioux Pharm
Summit Nutritionals
TSI Group
WanTuMing Biological
Yantai Dongcheng
YBCC
Yibao Group
Chondroitin Segment by Type
Food Grade
Pharmaceutical Grade
Chondroitin Segment by Application
Pharmacy
Health Products
Chondroitin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chondroitin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Chondroitin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chondroitin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Chondroitin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Chondroitin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Chondroitin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Food Grade
- Pharmaceutical Grade
Applications
- Pharmacy
- Health Products
Companies covered
- SANXIN
- Focus Chem
- GGI
- Guanglong Biochem
- Hengjie Bio-Pharmaceuticals
- Huiwen
- ISBA
- Jiaixng Hengjie
- Meitek
- Nippon Zoki
- Pacific Rainbow
- Qingdao Green-Extract
- QJBCHINA
- Runxin Biotechnology
- SANXIN GROUP
- Shandong Dongcheng
- Sioux Pharm
- Summit Nutritionals
- TSI Group
- WanTuMing Biological
- Yantai Dongcheng
- YBCC
- Yibao Group
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Chondroitin Market Size (2021-2032)
- 2.2.2 Global Chondroitin Sales (2021-2032)
- 2.2.3 Global Chondroitin Market Average Price (2021-2032)
- 2.3 Chondroitin by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Food Grade
- 2.3.3 Pharmaceutical Grade
- 2.4 Chondroitin by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pharmacy
- 2.4.3 Health Products
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Chondroitin Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Chondroitin Sales (Ton) of Manufacturers (2021-2026)
- 3.3 Global Chondroitin Revenue of Manufacturers (2021-2026)
- 3.4 Global Chondroitin Average Price by Manufacturers (2021-2026)
- 3.5 Global Chondroitin Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Chondroitin, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Chondroitin, Product Type & Application
- 3.8 Global Manufacturers of Chondroitin, Established Date
- 3.9 Global Chondroitin Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 SANXIN
- 4.1.1 SANXIN Company Information
- 4.1.2 SANXIN Business Overview
- 4.1.3 SANXIN Chondroitin Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 SANXIN Chondroitin Product Portfolio
- 4.1.5 SANXIN Recent Developments
- 4.2 Focus Chem
- 4.2.1 Focus Chem Company Information
- 4.2.2 Focus Chem Business Overview
- 4.2.3 Focus Chem Chondroitin Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Focus Chem Chondroitin Product Portfolio
- 4.2.5 Focus Chem Recent Developments
- 4.3 GGI
- 4.3.1 GGI Company Information
- 4.3.2 GGI Business Overview
- 4.3.3 GGI Chondroitin Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 GGI Chondroitin Product Portfolio
- 4.3.5 GGI Recent Developments
- 4.4 Guanglong Biochem
- 4.4.1 Guanglong Biochem Company Information
- 4.4.2 Guanglong Biochem Business Overview
- 4.4.3 Guanglong Biochem Chondroitin Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Guanglong Biochem Chondroitin Product Portfolio
- 4.4.5 Guanglong Biochem Recent Developments
- 4.5 Hengjie Bio-Pharmaceuticals
- 4.5.1 Hengjie Bio-Pharmaceuticals Company Information
- 4.5.2 Hengjie Bio-Pharmaceuticals Business Overview
- 4.5.3 Hengjie Bio-Pharmaceuticals Chondroitin Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Hengjie Bio-Pharmaceuticals Chondroitin Product Portfolio
- 4.5.5 Hengjie Bio-Pharmaceuticals Recent Developments
- 4.6 Huiwen
- 4.6.1 Huiwen Company Information
- 4.6.2 Huiwen Business Overview
- 4.6.3 Huiwen Chondroitin Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Huiwen Chondroitin Product Portfolio
- 4.6.5 Huiwen Recent Developments
- 4.7 ISBA
- 4.7.1 ISBA Company Information
- 4.7.2 ISBA Business Overview
- 4.7.3 ISBA Chondroitin Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 ISBA Chondroitin Product Portfolio
- 4.7.5 ISBA Recent Developments
- 4.8 Jiaixng Hengjie
- 4.8.1 Jiaixng Hengjie Company Information
- 4.8.2 Jiaixng Hengjie Business Overview
- 4.8.3 Jiaixng Hengjie Chondroitin Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Jiaixng Hengjie Chondroitin Product Portfolio
- 4.8.5 Jiaixng Hengjie Recent Developments
- 4.9 Meitek
- 4.9.1 Meitek Company Information
- 4.9.2 Meitek Business Overview
- 4.9.3 Meitek Chondroitin Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Meitek Chondroitin Product Portfolio
- 4.9.5 Meitek Recent Developments
- 4.10 Nippon Zoki
- 4.10.1 Nippon Zoki Company Information
- 4.10.2 Nippon Zoki Business Overview
- 4.10.3 Nippon Zoki Chondroitin Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Nippon Zoki Chondroitin Product Portfolio
- 4.10.5 Nippon Zoki Recent Developments
- 4.11 Pacific Rainbow
- 4.11.1 Pacific Rainbow Company Information
- 4.11.2 Pacific Rainbow Business Overview
- 4.11.3 Pacific Rainbow Chondroitin Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Pacific Rainbow Chondroitin Product Portfolio
- 4.11.5 Pacific Rainbow Recent Developments
- 4.12 Qingdao Green-Extract
- 4.12.1 Qingdao Green-Extract Company Information
- 4.12.2 Qingdao Green-Extract Business Overview
- 4.12.3 Qingdao Green-Extract Chondroitin Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Qingdao Green-Extract Chondroitin Product Portfolio
- 4.12.5 Qingdao Green-Extract Recent Developments
- 4.13 QJBCHINA
- 4.13.1 QJBCHINA Company Information
- 4.13.2 QJBCHINA Business Overview
- 4.13.3 QJBCHINA Chondroitin Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 QJBCHINA Chondroitin Product Portfolio
- 4.13.5 QJBCHINA Recent Developments
- 4.14 Runxin Biotechnology
- 4.14.1 Runxin Biotechnology Company Information
- 4.14.2 Runxin Biotechnology Business Overview
- 4.14.3 Runxin Biotechnology Chondroitin Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Runxin Biotechnology Chondroitin Product Portfolio
- 4.14.5 Runxin Biotechnology Recent Developments
- 4.15 SANXIN GROUP
- 4.15.1 SANXIN GROUP Company Information
- 4.15.2 SANXIN GROUP Business Overview
- 4.15.3 SANXIN GROUP Chondroitin Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 SANXIN GROUP Chondroitin Product Portfolio
- 4.15.5 SANXIN GROUP Recent Developments
- 4.16 Shandong Dongcheng
- 4.16.1 Shandong Dongcheng Company Information
- 4.16.2 Shandong Dongcheng Business Overview
- 4.16.3 Shandong Dongcheng Chondroitin Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Shandong Dongcheng Chondroitin Product Portfolio
- 4.16.5 Shandong Dongcheng Recent Developments
- 4.17 Sioux Pharm
- 4.17.1 Sioux Pharm Company Information
- 4.17.2 Sioux Pharm Business Overview
- 4.17.3 Sioux Pharm Chondroitin Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Sioux Pharm Chondroitin Product Portfolio
- 4.17.5 Sioux Pharm Recent Developments
- 4.18 Summit Nutritionals
- 4.18.1 Summit Nutritionals Company Information
- 4.18.2 Summit Nutritionals Business Overview
- 4.18.3 Summit Nutritionals Chondroitin Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Summit Nutritionals Chondroitin Product Portfolio
- 4.18.5 Summit Nutritionals Recent Developments
- 4.19 TSI Group
- 4.19.1 TSI Group Company Information
- 4.19.2 TSI Group Business Overview
- 4.19.3 TSI Group Chondroitin Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 TSI Group Chondroitin Product Portfolio
- 4.19.5 TSI Group Recent Developments
- 4.20 WanTuMing Biological
- 4.20.1 WanTuMing Biological Company Information
- 4.20.2 WanTuMing Biological Business Overview
- 4.20.3 WanTuMing Biological Chondroitin Sales, Revenue and Gross Margin (2021-2026)
- 4.20.4 WanTuMing Biological Chondroitin Product Portfolio
- 4.20.5 WanTuMing Biological Recent Developments
- 4.21 Yantai Dongcheng
- 4.21.1 Yantai Dongcheng Company Information
- 4.21.2 Yantai Dongcheng Business Overview
- 4.21.3 Yantai Dongcheng Chondroitin Sales, Revenue and Gross Margin (2021-2026)
- 4.21.4 Yantai Dongcheng Chondroitin Product Portfolio
- 4.21.5 Yantai Dongcheng Recent Developments
- 4.22 YBCC
- 4.22.1 YBCC Company Information
- 4.22.2 YBCC Business Overview
- 4.22.3 YBCC Chondroitin Sales, Revenue and Gross Margin (2021-2026)
- 4.22.4 YBCC Chondroitin Product Portfolio
- 4.22.5 YBCC Recent Developments
- 4.23 Yibao Group
- 4.23.1 Yibao Group Company Information
- 4.23.2 Yibao Group Business Overview
- 4.23.3 Yibao Group Chondroitin Sales, Revenue and Gross Margin (2021-2026)
- 4.23.4 Yibao Group Chondroitin Product Portfolio
- 4.23.5 Yibao Group Recent Developments
5 Global Chondroitin Market Scenario by Region
- 5.1 Global Chondroitin Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Chondroitin Sales by Region: 2021-2032
- 5.2.1 Global Chondroitin Sales by Region: 2021-2026
- 5.2.2 Global Chondroitin Sales by Region: 2027-2032
- 5.3 Global Chondroitin Revenue by Region: 2021-2032
- 5.3.1 Global Chondroitin Revenue by Region: 2021-2026
- 5.3.2 Global Chondroitin Revenue by Region: 2027-2032
- 5.4 North America Chondroitin Market Facts & Figures by Country
- 5.4.1 North America Chondroitin Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Chondroitin Sales by Country (2021-2032)
- 5.4.3 North America Chondroitin Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Chondroitin Market Facts & Figures by Country
- 5.5.1 Europe Chondroitin Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Chondroitin Sales by Country (2021-2032)
- 5.5.3 Europe Chondroitin Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Chondroitin Market Facts & Figures by Country
- 5.6.1 Asia Pacific Chondroitin Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Chondroitin Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Chondroitin Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Chondroitin Market Facts & Figures by Country
- 5.7.1 South America Chondroitin Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Chondroitin Sales by Country (2021-2032)
- 5.7.3 South America Chondroitin Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Chondroitin Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Chondroitin Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Chondroitin Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Chondroitin Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Chondroitin Sales by Type (2021-2032)
- 6.1.1 Global Chondroitin Sales by Type (2021-2032) & (Ton)
- 6.1.2 Global Chondroitin Sales Market Share by Type (2021-2032)
- 6.2 Global Chondroitin Revenue by Type (2021-2032)
- 6.2.1 Global Chondroitin Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Chondroitin Revenue Market Share by Type (2021-2032)
- 6.3 Global Chondroitin Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Chondroitin Sales by Application (2021-2032)
- 7.1.1 Global Chondroitin Sales by Application (2021-2032) & (Ton)
- 7.1.2 Global Chondroitin Sales Market Share by Application (2021-2032)
- 7.2 Global Chondroitin Revenue by Application (2021-2032)
- 7.2.1 Global Chondroitin Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Chondroitin Revenue Market Share by Application (2021-2032)
- 7.3 Global Chondroitin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Chondroitin Value Chain Analysis
- 8.1.1 Chondroitin Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Chondroitin Production Mode & Process
- 8.2 Chondroitin Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Chondroitin Distributors
- 8.2.3 Chondroitin Customers
9 Global Chondroitin Analyzing Market Dynamics
- 9.1 Chondroitin Industry Trends
- 9.2 Chondroitin Industry Drivers
- 9.3 Chondroitin Industry Opportunities and Challenges
- 9.4 Chondroitin Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst